Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed6
Terminated2

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT02175134Not ApplicableTerminated
IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis
Suspected Tuberculous Peritonitis
PrincipalinvestigatorStart date: 2014-07-01
NCT01087190Not ApplicableCompleted
Isoniazid (INH) Treatment Based on ELISPOT Assay
Kidney Transplant Recipient
Principalinvestigator
NCT02439372Completed
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis
Cytomegalovirus InfectionsDisease ExacerbationUlcerative Colitis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT02175134Not ApplicablePrincipalInvestigator

IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis

Suspected Tuberculous Peritonitis
Terminated
NCT02081729PrincipalInvestigator

Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)

Kidney Transplantation
Terminated
NCT00682045PrincipalInvestigator

Latent Tuberculosis Infection in Renal Transplant Recipients

Renal Transplant
Completed
NCT01021124PrincipalInvestigator

Latent Tuberculosis Infection in Bone Marrow Transplant Recipients

Tuberculosis
Completed
NCT01087190Not ApplicablePrincipalInvestigator

Isoniazid (INH) Treatment Based on ELISPOT Assay

Kidney Transplant Recipient
Completed
NCT02025335PrincipalInvestigator

Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Kidney Transplant Recipients

Kidney Transplantation Recipients
Completed
NCT02081716PrincipalInvestigator

Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)

Bone Marrow Transplantation
Completed
NCT02439372PrincipalInvestigator

Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis

Cytomegalovirus InfectionsDisease ExacerbationUlcerative Colitis
Completed

All 8 trials loaded